Company news

Botanix Pharmaceuticals Limited news in 2024

Botanix Pharmaceuticals Limited's news releases, calls and decks from 2024, newest first.

View company

First Sofdra Prescriptions as Commercialisation Ramps Up

December 16, 2024

Botanix Pharmaceuticals: Releases Quarterly Reports

October 28, 2024

September 2024 Quarterly Activities Report and Appendix 4C

October 27, 2024

Botanix Appendix 4E & Announcement of Commercial Day Webinar

August 30, 2024

June 2024 Quarterly Activities Report and Appendix 4C

July 30, 2024

Botanix $70 Million Institutional Capital Raising

June 21, 2024

FDA Approves Sofdra

June 19, 2024

Final Sofdra Labelling Discussions with FDA

June 11, 2024

March 2024 Quarterly Activities Report and Appendix 4C

April 30, 2024

S&P DJI Announces March 2024 Quarterly Rebalance

March 1, 2024

Botanix Pharmaceuticals Half Year Report

February 27, 2024

December 2023 Quarterly Activities Report and Appendix 4C

January 30, 2024

NDA Resubmission Accepted and Approval Date Confirmed

January 21, 2024

Decks in 2024